CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 280,679 | $463 | 0.05% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 35,000 | $58 | 0.04% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $30,088 | 0.02% |
| FinDec Wealth Services, Inc. | 16,000 | $26,400 | 0.02% |
| Atom Investors LP | 18,298 | $30,192 | 0.02% |
| Laurion Capital Management LP | 722,100 | $1,191,465 | 0.01% |
| Tortoise Investment Management, LLC | 15,000 | $24,750 | 0.00% |
| Callan Capital, LLC | 13,587 | $22,419 | 0.00% |
| Assenagon Asset Management S.A. | 394,994 | $651,740 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $6,600 | 0.00% |
| Renaissance Technologies | 331,308 | $547 | 0.00% |
| CITIGROUP INC | 651,161 | $1,074,416 | 0.00% |
| BLAIR WILLIAM & CO/IL | 130,500 | $215,325 | 0.00% |
| TWO SIGMA ADVISERS, LP | 143,500 | $236,775 | 0.00% |
| Belpointe Asset Management LLC | 11,454 | $18,899 | 0.00% |
| Gladstone Institutional Advisory LLC | 14,000 | $23,100 | 0.00% |
| Bank of New York Mellon Corp | 14,350 | $23,676 | 0.00% |
| Citadel Advisors | 3,700 | $6,105 | 0.00% |
| Citadel Advisors | 11,600 | $19,140 | 0.00% |
| Citadel Advisors | 7,007 | $11,562 | 0.00% |
External links
This page lists CARDIFF ONCOLOGY INC's shareholders in Q1 2023. To view CARDIFF ONCOLOGY INC's shareholder history, click here.